Supplementary Table S18. Half maximum inhibitory concentrations (IC50) for cisplatin, paclitaxel and olaparib in cell lines after CRISPR/Cas-9 mediated RB1 knockout.
Homologous recombination deficiency (HRD) is an approved predictive biomarker for Poly (ADP-ribose) polymerase inhibitors (PARPi) in ovarian cancer. However, the proportion of positive HRD in the real
BackgroundSeveral studies have established Glioblastoma Multiforme (GBM) prognostic and predictive models based on age and Karnofsky Performance Status (KPS), while very few studies evaluated the prog
Additional file 6: Table S6. Locus Discovery. High scoring SNPs from discover analysis. First tab is summary of SNP numbers by trait, remaining tabs are individual lists per trait.
